1 | ABP 959 | - | - | - | - | 1件: 62 62 💬
|
2 | ABP 959 - biosimilar TO eculizumab | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
3 | ABP 959 - proposed biosimilar TO eculizumab | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
4 | ACH-0144471 | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 2件: 62 62, 222 💬
|
5 | ACH-0145228 | - | - | - | - | 1件: 62 62 💬
|
6 | ACT-HIB | - | - | - | - | 3件: 14 14, 62, 222 💬
|
7 | ACT-HIB polvere E solvente PER soluzione iniettabile IN siringa preriempita 0,5 ML | - | - | - | - | 2件: 61 61, 62 💬
|
8 | Acthib - polvere E solvente PER soluzione iniettabile 1 flaconcino polvere+1 siringa preriempita solvente 0.5 ML | - | - | - | - | 2件: 62 62, 66 💬
|
9 | ADX-038 | - | - | - | - | 1件: 62 62 💬
|
10 | Allogeneic bone marrow transplantation | - | - | - | - | 8件: 60 60, 62, 65, 96, 164, 284, 285, 286 💬
|
11 | Allogeneic hematopoietic stem cell transplantation | - | - | - | - | 8件: 28 28, 51, 60, 62, 65, 164, 284, 285 💬
|
12 | Allogeneic stem cell transplantation | - | - | - | - | 5件: 19 19, 20, 49, 62, 84 💬
|
13 | ALN-62643 | - | - | - | - | 1件: 62 62 💬
|
14 | ALN-CC5 | - | - | - | - | 4件: 11 11, 62, 66, 109 💬
|
15 | ALXN1102 | - | - | - | - | 1件: 62 62 💬
|
16 | ALXN1103 | - | - | - | - | 1件: 62 62 💬
|
17 | ALXN1210 | - | - | - | - | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
18 | ALXN2040 | - | - | - | - | 1件: 62 62 💬
|
19 | ALXN2050 | - | - | - | - | 3件: 11 11, 62, 66 💬
|
20 | Anti haemophilus influeanze vaccination | - | - | - | - | 1件: 62 62 💬
|
21 | ANTI-C5 antibody | - | - | - | - | 4件: 11 11, 14, 62, 109 💬
|
22 | ANTI-thymocyte globulin | - | - | - | - | 18件: 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
|
23 | APL-2 | - | - | - | - | 5件: 2 2, 61, 62, 66, 222 💬
|
24 | Aspaveli | 1件: Pegcetacoplan Pegcetacoplan | 1件: Pegcetacoplan
Pegcetacoplan
💬
| 1件: C3 C3 💬
| 17件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 4件: 2 2, 61, 62, 222 💬
|
25 | BCD-148 | - | - | - | - | 1件: 62 62 💬
|
26 | BCX10013 | 1件: BCX10013 BCX10013 | - | - | - | 1件: 62 62 💬
|
27 | BCX9930 | - | - | - | - | 3件: 62 62, 66, 222 💬
|
28 | BCX9930 hydrochloride | - | - | - | - | 3件: 62 62, 66, 222 💬
|
29 | BCX9930 monotherapy | - | - | - | - | 1件: 62 62 💬
|
30 | Benzilpenicillina benzatinica | - | - | - | - | 1件: 62 62 💬
|
31 | Bexsero | - | - | - | - | 4件: 11 11, 13, 62, 222 💬
|
32 | Bexsero - sospensione iniettabile - USO intramuscolare - siringa P | - | - | - | - | 1件: 62 62 💬
|
33 | Bexsero - sospensione iniettabile - USO intramuscolare - siringa preriempita (vetro) - 0.5ML - 1 siringa preriempita CON AGO | - | - | - | - | 2件: 62 62, 66 💬
|
34 | Bexsero sospensione iniettabile IN siringa preriempita | - | - | - | - | 1件: 62 62 💬
|
35 | Bexsero – sospensione iniettabile – siringa preriempita | - | - | - | - | 2件: 61 61, 62 💬
|
36 | Biospecimen collection | - | - | - | - | 18件: 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
37 | Bone marrow aspiration | - | - | - | - | 8件: 2 2, 28, 60, 62, 65, 284, 285, 286 💬
|
38 | Bone marrow biopsy | - | - | - | - | 7件: 26 26, 28, 60, 62, 65, 284, 286 💬
|
39 | Bryostatin 1 | 1件: Bryostatin 1 Bryostatin 1 | - | - | - | 2件: 13 13, 62 💬
|
40 | C5 INH MAB, SKY59, RO/CH7092230 | - | - | - | - | 2件: 62 62, 109 💬
|
41 | C5 inhibitor | - | - | - | - | 1件: 62 62 💬
|
42 | Campath, chemo and/or TBI allo SCT | - | - | - | - | 3件: 60 60, 62, 283 💬
|
43 | Carbon-14 labeled HSK39297 | 1件: Activated charcoal Activated charcoal | 1件: Charcoal, activated
Charcoal, activated
💬
| - | - | 1件: 62 62 💬
|
44 | Cell infusion | - | - | - | - | 3件: 60 60, 62, 283 💬
|
45 | Cemdisiran | 1件: Cemdisiran Cemdisiran | - | - | - | 4件: 11 11, 62, 66, 109 💬
|
46 | Computed tomography | - | - | - | - | 12件: 26 26, 28, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
|
47 | Coversin | 1件: Nomacopan Nomacopan | 1件: Nomacopan
Nomacopan
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 62 62, 109 💬
|
48 | Crovalimab | 1件: Crovalimab Crovalimab | 1件: Crovalimab
Crovalimab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 62 62, 109 💬
|
49 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
50 | Cyclosporin A | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 46 46, 49, 53, 54, 56, 60, 62, 93, 95, 113, 164 💬
|
51 | Cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 28件: 11 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
|
52 | Cytoreductive regimen followed BY A CD34+E- selected allogeneic stem cell transplant | - | - | - | - | 1件: 62 62 💬
|
53 | Danicopan | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 2件: 62 62, 222 💬
|
54 | Echocardiography | - | - | - | - | 7件: 28 28, 58, 60, 62, 65, 284, 286 💬
|
55 | Eculizumab | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 8件: 11 11, 13, 14, 61, 62, 109, 221, 222 💬
|
56 | Eculizumab injection | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
57 | FC- and CDR-modified humanised monoclonal antibody against C5 | - | - | - | - | 3件: 11 11, 62, 109 💬
|
58 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 29件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
59 | Fludarabine | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 23件: 11 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
|
60 | Fludarabine phosphate | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 12件: 28 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 💬
|
61 | G-CSF | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 18件: 2 2, 6, 11, 13, 16, 22, 47, 49, 51, 60, 61, 62, 65, 85, 96, 284, 285, 331 💬
|
62 | Gelatin | 1件: Gelatin Gelatin | 2件: Gelatin
Gelatin
,
Donkey glue
💬
| - | - | 3件: 47 47, 62, 70 💬
|
63 | H5g1.1-MAB | - | - | - | - | 3件: 13 13, 50, 62 💬
|
64 | Haemophilus influenzae | - | - | - | - | 2件: 62 62, 66 💬
|
65 | Hiberix - polvere E solvente PER soluzione iniettabile PER USO intramuscolare 1 flaconcino DI polvere + 1 siringa preriempita DI solvente DA 0.5 ML | - | - | - | - | 3件: 61 61, 62, 66 💬
|
66 | HRS-5965 capsule | - | - | - | - | 1件: 62 62 💬
|
67 | HRS-5965 capsules | - | - | - | - | 2件: 62 62, 66 💬
|
68 | HRS-5965 tablets | - | - | - | - | 2件: 62 62, 66 💬
|
69 | HSK39297 | - | - | - | - | 1件: 62 62 💬
|
70 | HSK39297 tablets | - | - | - | - | 1件: 62 62 💬
|
71 | Human monoclonal antibody directed against complement 5 protein | - | - | - | - | 1件: 62 62 💬
|
72 | Humanized ANTI-factor BB monoclonal antibody | - | - | - | - | 1件: 62 62 💬
|
73 | Iptacopan | 1件: Iptacopan Iptacopan | 2件: Iptacopan
Iptacopan
,
Iptacopan hydrochloride
💬
| 1件: CFB CFB 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 6件: 11 11, 61, 62, 66, 109, 222 💬
|
74 | Iron dextran | 2件: Iron Iron, Iron Dextran | 2件: Ferrous fumarate
Ferrous fumarate
,
Iron dextran
💬
| - | - | 2件: 62 62, 97 💬
|
75 | Iron sucrose | 2件: Iron Iron, Iron sucrose | 2件: Ferrous fumarate
Ferrous fumarate
,
Iron sucrose
💬
| - | - | 3件: 62 62, 96, 97 💬
|
76 | KP104 | - | - | - | - | 3件: 49 49, 62, 66 💬
|
77 | L04aa25 | - | - | - | - | 1件: 62 62 💬
|
78 | Laboratory biomarker analysis | - | - | - | - | 22件: 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
79 | Lapine T-lymphocyte immune globulin | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 4件: 62 62, 65, 284, 286 💬
|
80 | Levamisole+cyclosporin A+glucocorticoids | 2件: Cyclosporine Cyclosporine, Levamisole | 3件: Cyclosporine
Cyclosporine
,
Levamisole hydrochloride
,
Levamisole
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 60 60, 62 💬
|
81 | LFG316 | - | - | - | - | 1件: 62 62 💬
|
82 | LNP023 | - | - | - | - | 5件: 61 61, 62, 66, 109, 222 💬
|
83 | LNP023 hydrochloride salt | - | - | - | - | 2件: 62 62, 222 💬
|
84 | Melphalan | 1件: Melphalan Melphalan | 2件: Melphalan
Melphalan
,
Melphalan hydrochloride
💬
| - | - | 19件: 11 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
|
85 | Menveo | - | - | - | - | 4件: 11 11, 13, 62, 222 💬
|
86 | Menveo - polv.E soluz.PER soluz. iniett.-USO intramuscolare-comp. coniug.liofilizz.mena:flac.(vetro) comp. goniug.liqui.mencwy:flac.(vetro)-1 flac+1flac | - | - | - | - | 2件: 62 62, 66 💬
|
87 | Menveo polvere E soluzione PER soluzione iniettabile | - | - | - | - | 1件: 62 62 💬
|
88 | Menveo – polvere E soluzione PER soluzione iniettabile | - | - | - | - | 2件: 61 61, 62 💬
|
89 | Methotrexate | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 37件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
90 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
91 | Miltenyi biotec clinimacs | - | - | - | - | 2件: 62 62, 326 💬
|
92 | Miltenyi clinimacs | - | - | - | - | 2件: 62 62, 285 💬
|
93 | Multigated acquisition scan | - | - | - | - | 5件: 60 60, 62, 65, 284, 286 💬
|
94 | MY008211A tablets | - | - | - | - | 2件: 62 62, 66 💬
|
95 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 32件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
96 | Myeloablative preparative regimen | - | - | - | - | 3件: 62 62, 65, 284 💬
|
97 | NM8074 | - | - | - | - | 4件: 50 50, 62, 66, 109 💬
|
98 | Nonmyeloablative allogeneic hematopoietic stem cell transplantation | - | - | - | - | 6件: 28 28, 51, 60, 62, 65, 285 💬
|
99 | NTQ5082 | - | - | - | - | 1件: 62 62 💬
|
100 | OMS906 study drug | 1件: OMS906 OMS906 | - | - | - | 1件: 62 62 💬
|
101 | OMS906 study drug - 3 MG/KG | 1件: OMS906 OMS906 | - | - | - | 1件: 62 62 💬
|
102 | OMS906 study drug - 5 MG/KG | 1件: OMS906 OMS906 | - | - | - | 1件: 62 62 💬
|
103 | Pegcetacoplan | 1件: Pegcetacoplan Pegcetacoplan | 1件: Pegcetacoplan
Pegcetacoplan
💬
| 1件: C3 C3 💬
| 17件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 4件: 2 2, 61, 62, 222 💬
|
104 | Peripheral blood stem cell transplantation | - | - | - | - | 12件: 11 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
|
105 | Peripheral blood stem cells | - | - | - | - | 4件: 51 51, 60, 62, 65 💬
|
106 | Pharmacological study | - | - | - | - | 7件: 28 28, 34, 62, 74, 89, 232, 331 💬
|
107 | Pneumovax - 10 siringhe preriempite CON AGO DA 0.5 ML | - | - | - | - | 1件: 62 62 💬
|
108 | Pneumovax – soluzione iniettabile IN siringa preriempita DA 0,5 ML | - | - | - | - | 2件: 62 62, 66 💬
|
109 | Polisaccaride dell'haemophilus influenzae DI tipo B coniugato CON LA proteina tetanica | - | - | - | - | 1件: 62 62 💬
|
110 | POST-transplant G-CSF | - | - | - | - | 3件: 60 60, 62, 283 💬
|
111 | Pozelimab | 1件: Pozelimab Pozelimab | 1件: Pozelimab
Pozelimab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 11 11, 62 💬
|
112 | Prevenar 13 - 0.5 ML sospension | - | - | - | - | 1件: 62 62 💬
|
113 | Quality-OF-life assessment | - | - | - | - | 11件: 28 28, 34, 36, 51, 62, 63, 65, 96, 284, 286, 298 💬
|
114 | RA101495 | - | - | - | - | 1件: 62 62 💬
|
115 | RA101495 sodium | - | - | - | - | 1件: 62 62 💬
|
116 | Rabbit ATG | 2件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 4件: 60 60, 62, 283, 285 💬
|
117 | Ravulizumab | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
118 | Ravulizumab obds | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
119 | Reduced intensity preparative regimen | - | - | - | - | 3件: 62 62, 65, 284 💬
|
120 | Reduced toxicity ablative regimen | - | - | - | - | 3件: 62 62, 65, 284 💬
|
121 | REGN3918 | - | - | - | - | 2件: 11 11, 62 💬
|
122 | Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
123 | RO7112689 | - | - | - | - | 1件: 62 62 💬
|
124 | RO7112689/F01 | - | - | - | - | 1件: 62 62 💬
|
125 | RO7112689/F03-01 | - | - | - | - | 2件: 62 62, 109 💬
|
126 | RO7112689/F03-03 | - | - | - | - | 1件: 62 62 💬
|
127 | RO7112689/F03-10 | - | - | - | - | 2件: 62 62, 109 💬
|
128 | RVA576 | - | - | - | - | 3件: 62 62, 109, 162 💬
|
129 | Sargramostim | 1件: Sargramostim Sargramostim | 1件: Sargramostim
Sargramostim
💬
| 1件: CSF2RA CSF2RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 7件: 6 6, 28, 60, 62, 96, 229, 285 💬
|
130 | Sirolimus | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 39件: 6 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
131 | Solaris | - | - | - | - | 2件: 62 62, 109 💬
|
132 | Soliris | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 6件: 11 11, 13, 14, 62, 109, 222 💬
|
133 | Soliris 300 | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
134 | Soliris 300 MG concentrate FOR solution FOR infusion | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
135 | Soliris 300MG/30ML | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
136 | Stem cell transplantation | - | - | - | - | 13件: 13 13, 19, 20, 46, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
|
137 | Synthetic 15-amino-acid macrocyclic peptide | - | - | - | - | 1件: 62 62 💬
|
138 | Synthetic 15-amino-acid macrocyclic peptide acylated with A ethyleneglycol24 | - | - | - | - | 1件: 62 62 💬
|
139 | Synthetic 15-amino-acid macrocyclic peptide acylated with A ethyleneglycol24 palmitoylated linker | - | - | - | - | 1件: 62 62 💬
|
140 | Synthetic 15-amino-acid macrocyclic peptide acylated with A polyethyleneglycol palmitoylated linker | - | - | - | - | 1件: 62 62 💬
|
141 | Systematic chemotherapy and antibodies | - | - | - | - | 1件: 62 62 💬
|
142 | Systemic chemotherapy and antibodies | - | - | - | - | 2件: 62 62, 326 💬
|
143 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 31件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
|
144 | Tetract-HIB - 1 siringa precaricata 0.5 ML | - | - | - | - | 2件: 62 62, 222 💬
|
145 | Total body irradiation | - | - | - | - | 13件: 19 19, 20, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284, 285 💬
|
146 | Total-body irradiation | - | - | - | - | 9件: 28 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
|
147 | Treosulfan | 1件: Treosulfan Treosulfan | 1件: Treosulfan
Treosulfan
💬
| - | - | 6件: 13 13, 19, 62, 65, 284, 286 💬
|
148 | Tretinoin | 1件: Tretinoin Tretinoin | 1件: Tretinoin
Tretinoin
💬
| 3件: PML PML, RARA, RARB 💬
| 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 3件: 62 62, 63, 75 💬
|
149 | Ultomiris | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
150 | Ultomiris - 300 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) 3 ML (100 MG / ML) - 1 flaconcino | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
151 | Ultomiris 300MG/30ML | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
152 | Vaccino contro IL memingococco DI gruppo B | - | - | - | - | 3件: 61 61, 62, 66 💬
|
153 | Vaccino haemophilus influenzae B coniugato CON proteina difterica CRM197 | - | - | - | - | 1件: 62 62 💬
|
154 | Vaccino haemophilus influenzae B coniugato CON tossoidetetanico | - | - | - | - | 3件: 61 61, 62, 66 💬
|
155 | Vaccino meningococcico polisaccaridico | - | - | - | - | 1件: 62 62 💬
|
156 | Vaccino pneumococcico | - | - | - | - | 2件: 62 62, 66 💬
|
157 | Vari | - | - | - | - | 2件: 62 62, 274 💬
|
158 | X-RAY imaging | - | - | - | - | 5件: 28 28, 62, 65, 284, 286 💬
|
159 | XH-S003 capsule | - | - | - | - | 1件: 62 62 💬
|
160 | Zilucoplan | 1件: Zilucoplan Zilucoplan | 2件: Zilucoplan sodium
Zilucoplan sodium
,
Zilucoplan
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 11 11, 62 💬
|